The study is published in the Proceedings of the National Academy of Sciences in an article titled, “Targeted degradation of ...

Key Business Updates BRUKINSA ® (zanubrutinib) is an orally available, small molecule inhibitor of BTK designed to deliver ...

University of California, Riverside scientists have designed novel agents that bind to and degrade Pin1, a protein linked to ...

KinCon biolabs now uses its technology to predict and this in living cells, whether drug candidates effectively bind to ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins.

KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...

Richard F. Ludueña, Professor Emeritus at the University of Texas Health San Antonio, discusses his innovative approach to ...

Discover the role of amino acids for muscle growth & how they impact protein synthesis, recovery, & performance. Learn which ...